Sponsored by:

Molecular Imaging: Page 285

UMRi, DDD-Diagnostic sign distribution deal
By AuntMinnie.com staff writers
Universal Medical Resources (UMRi) has signed an agreement to be the exclusive distributor for the new Quantum Cam gamma camera from Danish nuclear medicine firm DDD-Diagnostic.
November 15, 2012
Positron appoints Conroy to COO post
By AuntMinnie.com staff writers
PET vendor Positron announced it has named Charles Conroy as chief operating officer (COO).
November 14, 2012
International Isotopes' revenue declines in Q3
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes cited an overall reduction in operating nuclear medicine clinics in the U.S. and budgetary constraints at a number of facilities as two reasons for a decrease in revenue in the third-quarter and nine-month periods.
November 14, 2012
PET/MRI shows promise in gynecologic cancer patients
By Wayne Forrest
Monday, November 26 | 10:40 a.m.-10:50 a.m. | SSC13-02 | Room S505ABSimultaneous PET/MRI is confirming its ability to visualize integrated anatomic, metabolic, and functional activity in a study of gynecologic cancer patients at Washington University in St. Louis.
November 14, 2012
MPH-SPECT, MRI show bone erosion in rheumatoid arthritis
By Wayne Forrest
Sunday, November 25 | 10:45 a.m.-10:55 a.m. | SSA14-01 | Room E451BA combination of multipinhole (MPH) SPECT and MRI could provide valuable information to improve therapeutic decisions for patients with rheumatoid arthritis, German researchers will report in this Sunday scientific session.
November 14, 2012
Breast MR more effective in identifying DCIS than BSGI
By Kate Madden Yee
Tuesday, November 27 | 11:40 a.m.-11:50 a.m. | SSG01-08 | Arie Crown TheaterMRI has higher sensitivity for detecting ductal carcinoma in situ (DCIS) and is more helpful than breast-specific gamma imaging (BSGI) in cases with no calcification on mammography, according to this Tuesday morning study conducted by Korean researchers.
November 13, 2012
Low-dose MBI safe adjunct to screening mammo
By Kate Madden Yee
Tuesday, November 27 | 10:40 a.m.-10:50 a.m. | SSG01-02 | Arie Crown TheaterLow-dose molecular breast imaging (MBI) is a viable adjunct to screening mammography in women with dense breasts, according to Mayo Clinic researchers.
November 13, 2012
BSGI boosts breast cancer detection in women with dense tissue
By Kate Madden Yee
Monday, November 26 | 10:10 a.m.-10:20 a.m. | VSMI21-09 | Arie Crown TheaterWhen used in conjunction with mammography, breast-specific gamma imaging (BSGI) increases cancer detection by 2.5% in women with dense breast tissue, which is comparable to the 2.1% increase in detection reported for breast MRI, according to researchers from George Washington University.
November 13, 2012
US matches MRI in identifying lesions seen on BSGI
By Kate Madden Yee
Monday, November 26 | 10:00 a.m.-10:10 a.m. | VSMI21-08 | Arie Crown TheaterMore than 50% of lesions seen on breast-specific gamma imaging (BSGI) can also be visualized with targeted ultrasound -- a percentage comparable to MRI results, according to researchers from George Washington University.
November 13, 2012
FDG-PET/CT works for primary breast cancer staging
By Kate Madden Yee
Sunday, November 25 | 11:15 a.m.-11:25 a.m. | SSA18-04 | Room S505ABFDG-PET/CT may be used as primary staging modality in patients with primary breast cancer, according to this Sunday morning presentation to be given by German researchers.
November 13, 2012
Method segments functional, anatomic areas on PET/MRI
By Erik L. Ridley
Tuesday, November 27 | 11:40 a.m.-11:50 a.m. | SSG09-08 | Room S402ABA team from the U.S. National Institutes of Health will present a segmentation method that can simultaneously and automatically delineate regions of radiotracer uptake and corresponding anatomical structures on PET/MRI scans.
November 11, 2012
PET volume, glycolytic activity predict NSCLC local recurrence
By Wayne Forrest
By characterizing non-small cell lung cancer (NSCLC) tumors through glycolytic activity and FDG-PET volume after stereotactic body radiation therapy, clinicians may be able to detect which tumors are likely to recur, according to a study presented at the American Society for Radiation Oncology meeting.
November 8, 2012
Previous Page
Page 285 of 615
Next Page